PhenoSign
Developer of in‑situ, time‑stamped, multi‑modal body fluid analysis systems. The organization combines microfluidics, photonics, microsensors, bioinformatics and computational models (including AI/ML) to generate real‑time biomarker data for clinical monitoring, early detection and research. Activities include collaborative clinical validation, academic research partnerships and dissemination of technical whitepapers and podcasts.
Industries
Nr. of Employees
small (1-50)
PhenoSign
Products
System for body liquid analysis
A clinically oriented system concept for in‑situ, time‑stamped, multi‑modal analysis of body fluids intended to provide real‑time biomarker data for monitoring and diagnostic applications.
System for body liquid analysis
A clinically oriented system concept for in‑situ, time‑stamped, multi‑modal analysis of body fluids intended to provide real‑time biomarker data for monitoring and diagnostic applications.
Services
Collaborative research agreements with academic and clinical partners to co‑develop and validate body fluid diagnostic technologies.
Support for designing and executing clinical validation studies in partnership with clinical sites to assess diagnostic performance.
Distribution of whitepapers, podcasts and informational material on real‑time diagnostics, precision medicine and system design.
Collaborative research agreements with academic and clinical partners to co‑develop and validate body fluid diagnostic technologies.
Support for designing and executing clinical validation studies in partnership with clinical sites to assess diagnostic performance.
Distribution of whitepapers, podcasts and informational material on real‑time diagnostics, precision medicine and system design.
Expertise Areas
- Body fluid diagnostics
- Point‑of‑care and ICU monitoring
- Clinical validation and trial collaboration
- Microfluidics and lab‑on‑a‑chip systems
Key Technologies
- Microfluidics
- Lab‑on‑a‑chip
- Photonics
- Microsensors